Reasons to be cheerful? Experts discuss state of the industry in 2023
It’s not all doom and gloom in the biopharma sector, say industry experts n a State of the Industry discussion at BWB 2023.
September 28, 2022
PerkinElmer says that its Cellaca PLX system is the cell analysis solution to streamline cell and gene therapy research and production.
BioProcess Insider is back at BPI Boston – part of Biotech Week Boston – after three years away where among the many exhibitors PerkinElmer has launched its Cellaca PLX image cytometry system.
According to the company, the technology designed by the firm’s Nexcelom unit offers researchers expanded cell sample critical quality attributes (CQA) beyond flow cytometry and staining methods. Additionally, PerkinElmer said the benchtop platform has been designed to assess numerous CQAs of cell samples in a single automated workflow, which includes cell identity, quality, and quantity.
Cellaca PLX and Reagents. Image c/o PerkinElmer
“Pharmaceutical companies have invested heavily in cell and gene therapy, but they struggle to assess the complex cell samples required to meet immense scientific demands and regulatory rigor across their research and manufacturing processes,” said Alan Fletcher, senior vice president, Life Sciences, PerkinElmer.
“While the Cellaca PLX Image Cytometer platform is therapeutic area agnostic, it is expected to be especially beneficial for researchers working in CAR-T cell therapy who want to streamline their phenotyping of immune cells for downstream processes.”
The firm claims the platform shortens the downstream processing time “by multiplexing with four channels with viability readouts at one minute per sample.” Furthermore, it says that there is no need for extra incubations, washes, titrations, or decontamination due to the predefined assays, templates, ready-to-use reagent kits, and enable flow-cytometry-like data analysis.
Furthermore, PerkinElmer says the system does not require any complex calibration procedures of intense training needs and to support the customer experience, reagent kits and antibodies from the company’s BioLegend business are also included as part of the solution.
Editor, BioProcess Insider
Journalist covering global biopharmaceutical manufacturing and processing news and host of the Voices of Biotech podcast.
I am currently living and working in London but I grew up in Lincolnshire (UK) and studied in Newcastle (UK).
Got a story? Feel free to email me at [email protected]
Ins & Outs: Gonzalez but not forgotten at AbbVieFeb 29, 2024
Miltenyi: MoU ‘paves way’ for India’s CGT ambitionsFeb 29, 2024
Experic expands into Europe with Ireland facilityFeb 29, 2024
Peas in a pod: BioCina and NovaCina ink fill/finish dealFeb 28, 2024